Get started
Author

Yuliza Shotts

Abundance of C1q Expressing Macrophages Promotes Resistance to Modern Therapy
2024 · Caleb K Stein, Erin W Meermeier, et al. · Blood · 3
PDF
Celmod-Dexamethasone Combination Overcomes Primary Resistance to T Cell Engagers Caused By High Tumor Burden in a Human CRBN+ Preclinical Model of Multiple Myeloma
2024 · Erin W Meermeier, Meaghen Sharik, et al. · Blood · 2
PDF
Retention of immunosuppressive C1Q macrophages following therapeutic interventions imparts negative outcomes across human multiple myeloma studies
2025 · Caleb Stein, Erin Meermeier, et al. · Blood · 1
Establishment and characterization of multiple myeloma cell lines from a single patient’s disease course immortalizes clonal heterogeneity
2026 · JE Wiedmeier-Nutor, DL Riggs, et al. · Blood Cancer Journal
PDF
Establishment and characterization of multiple myeloma cell lines from a single patient’s disease course immortalizes clonal heterogeneity
2026 · P. Leif Bergsagel, Julia E. Wiedmeier-Nutor, et al. · Research Square
PDF
Combination with Cytotoxic Therapy and Checkpoint Blockade Overcomes Primary Resistance to BCMA Bispecific Antibody Therapy and Leads to Durable Remission of Vk*MYC Multiple Myeloma
2024 · Erin W Meermeier, Caleb K Stein, et al. · Blood
Works count: 6
Citation count: 6
H-index: 2
I10-index:
Year
Topic
Type